Literature DB >> 1167377

Phototherapy in newborn infants with severe rhesus hemolytic disease.

J Moller, F Ebbesen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167377     DOI: 10.1016/s0022-3476(75)80725-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  Blue double light. Improved method of phototherapy.

Authors:  F Ebbsen; J Moller
Journal:  Arch Dis Child       Date:  1976-06       Impact factor: 3.791

2.  Controlled trial of antenatal barbiturates in rhesus haemolytic disease.

Authors:  S H Towers; G P McMullin
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

Review 3.  Use of phototherapy for neonatal hyperbilirubinemia. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1986-06-01       Impact factor: 8.262

4.  Superiority of intensive phototherapy--blue double light--in rhesus haemolytic disease.

Authors:  F Ebbesen
Journal:  Eur J Pediatr       Date:  1979-04-03       Impact factor: 3.183

5.  Correlation of cord bilirubin levels with hyperbilirubinaemia in ABO incompatibility.

Authors:  H M Risemberg; E Mazzi; M G MacDonald; M Peralta; F Heldrich
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

6.  Safety and efficacy of filtered sunlight in treatment of jaundice in African neonates.

Authors:  Tina M Slusher; Hendrik J Vreman; Bolajoko O Olusanya; Ronald J Wong; Ann M Brearley; Yvonne E Vaucher; David K Stevenson
Journal:  Pediatrics       Date:  2014-06       Impact factor: 7.124

7.  Evaluation of the indications for early exchange transfusion in rhesus haemolytic disease during phototherapy.

Authors:  F Ebbesen
Journal:  Eur J Pediatr       Date:  1980       Impact factor: 3.183

8.  Late anaemia in infants with rhesus haemolytic disease treated with intensive phototherapy.

Authors:  F Ebbesen
Journal:  Eur J Pediatr       Date:  1979-04-03       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.